Alicia K Morgans

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. doi request reprint Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy
    Alicia K Morgans
    School of Medicine, Vanderbilt University, Nashville, Tennessee Electronic address
    J Urol 193:1226-31. 2015
  2. pmc Bone-targeted agents: preventing skeletal complications in prostate cancer
    Alicia K Morgans
    Department of Hematology Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA
    Urol Clin North Am 39:533-46. 2012
  3. pmc Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy
    Alicia K Morgans
    Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
    Cancer 119:863-70. 2013
  4. doi request reprint Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment
    Matthew J Resnick
    Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee Geriatric Research Education and Clinical Center, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee
    Cancer 120:1263-71. 2014
  5. pmc Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer
    Alicia K Morgans
    Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA
    J Urol 187:889-93. 2012

Detail Information

Publications5

  1. doi request reprint Influence of age on incident diabetes and cardiovascular disease in prostate cancer survivors receiving androgen deprivation therapy
    Alicia K Morgans
    School of Medicine, Vanderbilt University, Nashville, Tennessee Electronic address
    J Urol 193:1226-31. 2015
    ..Using data from the population based PCOS we evaluated whether age at diagnosis and comorbidity impact the association of androgen deprivation therapy with incident diabetes and cardiovascular disease...
  2. pmc Bone-targeted agents: preventing skeletal complications in prostate cancer
    Alicia K Morgans
    Department of Hematology Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA
    Urol Clin North Am 39:533-46. 2012
    ..ADT results in bone loss and fragility fractures. This review describes the biology of bone metastases, skeletal morbidity, and recent advances in bone-targeted therapies to prevent skeletal complications of prostate cancer...
  3. pmc Bone density testing among prostate cancer survivors treated with androgen-deprivation therapy
    Alicia K Morgans
    Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA
    Cancer 119:863-70. 2013
    ..Guidelines recommend bone density testing before and during ADT to characterize fracture risk. The authors of the current report assessed bone density testing among men who received ADT for ≥ 1 year...
  4. doi request reprint Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment
    Matthew J Resnick
    Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee Geriatric Research Education and Clinical Center, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee
    Cancer 120:1263-71. 2014
    ..They also explored the associations between baseline function and age, comorbidity, and timing of baseline survey completion with respect to treatment...
  5. pmc Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer
    Alicia K Morgans
    Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA
    J Urol 187:889-93. 2012
    ..Using data from a prospective clinical trial we compared bone mineral density and fracture between African-American and Caucasian men receiving androgen deprivation therapy...